The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

胰岛素输送和糖尿病技术领先企业Tandem Diabetes Care, Inc. (TNDM)在2024年第三季度财报电话会议上报告了公司历史上最高的季度销售额。总裁兼首席执行官John ...

We are excited to work with Abbott to empower healthcare providers and people living with diabetes to ... Clinics and health ...

Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's ...

Dexcom G7 (adults and children 2 years and older) Dexcom CGM products require a prescription. Abbott's FreeStyle Libre CGM ...

Now iLet Users Have a Choice of iCGMs to Customize Their Diabetes ManagementIRVINE, CA / ACCESSWIRE / October 30, 2024 / Beta ...

Many of us with loved ones living with diabetes want to see them thrive. We often think of ways we can ease some of their ...

Tidepool collaborates with Abbott for seamless data integration ... to initiate the connection with their patients using FreeStyle Libre 2 and 3 systems in clinic or remotely.

由于第三季度表现强劲，Abbott Laboratories提高了全年利润预期，这主要得益于其医疗设备（包括FreeStyle Libre血糖监测仪）的强劲销售。公司的医疗设备部门报告销售额为47.5亿美元，超过分析师平均预期的46.8亿美元。